Myelo Therapeutics GmbH

🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
3
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia
Phase 2
Completed
- Conditions
- Chemotherapy-Induced NeutropeniaMyelosuppressionBreast Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2017-11-24
- Lead Sponsor
- Myelo Therapeutics GmbH
- Target Recruit Count
- 137
- Registration Number
- NCT02692742
- Locations
- 🇩🇪
Site 20, Aachen, Germany
🇩🇪Site 16, Aurich, Germany
🇩🇪Site 21, Dresden, Germany
News
No news found